The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells

Diabetologia

Volumn 39, Issue 8, 1996, Pages 875-890

  Eizirik, D L ^a,b   Flodstrom M ^b   Karlsen, A E ^c   Welsh, N ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UPPSALA UNIVERSITY   (Sweden)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

Beta cells; Insulin dependent diabetes mellitus; Insulin producing cells; Nitric oxide; Nitric oxide synthase; Nuclear factor B; Pancreatic islets; Promoter; Superoxide dismutase; Transcription factor

Indexed keywords

CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NUCLEAR FACTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

EID: 0030005411     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00403906     Document Type: Review

References (166)

1. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012
2. Lowenstein CJ, Dinerman JL, Snyder SH (1994) Nitric oxide: a physiologic messenger. Ann Intern Med 120: 227-237
3. Griffith OW, Stuher DJ (1995) Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 57: 707-736
4. Xie Q-W, Nathan C (1994) The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 56: 576-582
5. Nathan CF (1995) Natural resistance and nitric oxide. Cell 82: 873-876
6. Nussler AK, Di Silvio M, Billiar TR et al. (1992) Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176: 261-264
7. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr., McDaniel ML (1993) Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90: 1731-1735
8. Eizirik DL, Sandler S, Welsh N et al. (1994) Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93: 1968-1974
9. Albina JE (1995) On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 58: 643-649
10. Bach J-F (1995) Insulin-dependent diabetes mellitus as a β-cell targeted disease of immunoregulation. J Autoimmun 8: 439-463
11. Eizirik DL, Sandler S, Palmer JP (1993) Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM? Diabetes 42: 1389-1391
12. Mandrup-Poulsen T, Helquist S, Wogensen L et al. (1990) Cytokines and free radicals as effector molecules in the destruction of pancreatic beta-cells. Curr Top Microbiol Immunol 164: 169-193
13. Rabinovitch A (1993) Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev 1: 215-240
14. Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M, Welsh N (1991) Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 10: 241-253
15. Eizirik DL, Sandler S, Welsh N, Bendtzen K, Hellerström C (1994) Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines. Autoimmunity 19: 193-198
16. Rabinovitch A, Suarez-Pinzon WL, Strynadka K et al. (1994) Human islet destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 79: 1058-1062
17. Southern C, Schulster D, Green IC (1990) Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-α via an L-arginine dependent nitric oxide generating mechanism. FEBS Lett 276: 42-44
18. Eizirik DL, Leijerstam F (1994) The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Diabet Metab 20: 116-122
19. Welsh N, Eizirik DL, Bendtzen K, Sandler S (1991) Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129: 3167-3173
20. Eizirik DL, Welsh N, Niemann A, Velloso LA, Malaisse WJ (1994) Succinic acid monomethyl ester protect rat pancreatic islet secretory potential against interleukin-1β (IL-1β) without affecting glutamate decarboxylase expression or nitric oxide production. FEBS Lett 337: 298-302
21. Delaney CA, Green MHL, Lowe JE, Green IC (1993) Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the "comet" assay. FEBS Lett 333: 291-295
22. Fehsel K, Jalowy A, Qi S, Burkart V, Harmann B, Kolb H (1993) Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42: 496-500
23. Corbett JA, McDaniel ML (1992) Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 41: 897-903
24. Kolb H, Kolb-Bachofen V (1992) Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia 35: 796-797
25. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA 91: 9235-9256
26. Eizirik DL, Delaney CA, Green MHL et al. (1996) Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol 118: 71-83
27. Eizirik DL, Cagliero E, Björklund A, Welsh N (1992) Interleukin-1β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells which is similar to that observed an activated macrophages. FEBS Lett 308: 249-252
28. Karlsen AE, Andersen HU, Vissing SB et al. (1995) Cloning and expression of a cytokine inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44: 753-758
29. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714-718
30. Nakane M, Schmidt HHHW, Pollock JS, Förstermann U, Murad F (1993) Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316: 175-180
31. Lamas S, Marsden PA, Gordon KL, Tempst P, Michel T (1992) Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89: 6348-6352
32. Janssens SP, Shimouchi A, Quertermous T, Block DB, Block KD (1992) Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267: 14519-14522
33. Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T (1992) Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 207: 287-293
34. Snyder SH (1992) Nitric oxide: first in a new class of neurotransmitters. Science 257: 494-496
35. Rees DD, Palmer RMJ, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86: 3375-3378
36. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH (1992) Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Nat Acad Sci USA 89: 6711-6715
37. Xie Q-W, Cho HJ, Calaycay J et al. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228
38. Lyons RC, Orloff GJ, Cunningham JM (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370-6374
39. Charles JG, Palmer RMJ, Hickery MS et al. (1993) Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90: 11419-11423
40. Geller DA, Lowenstein CJ, Shapiro RA et al. (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocyles. Proc Natl Acad Sci USA 90: 3491-3495
41. Chartrain NA, Geller DA, Koty PP et al. (1994) Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269: 6765-6772
42. Förstermann U, Kleinert H (1995) Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg's Arch Pharmacol 352: 351-364
43. Marletta MA (1993) Nitric oxide synthase structure and mechanism. J Biol Chem 268: 12231-12234
44. Cho HJ, Xie O, Calaycay J et al. (1992) Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176: 599-604
45. Gerling I, Karlsen AE, Chapman HD et al. (1994) The inducible nitric oxide synthase gene, Nos2, maps to mouse chromosome 11. Mammal Genome 5: 318-320
46. Xu W, Gorman P, Sheer D et al. (1993) Regional localization of the gene coding for human brain nitric oxide synthase (NOS1) to 12q24.1 to 24.31 by fluorescent in situ hybridization. Cytogenet Cell Genet 64: 62-63
47. Marsden PA, Heng HHQ, Scherer SW et al. (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268: 17478-17488
48. Marsden PA, Heng HH, Duff CL, Shi X-M, Tsui L-C, Hall AV (1994) Localization of the human gene for inducible nitric oxide synthase (NOS2) to chromosome 17q11.2-q12. Genomics 19: 183-185
49. Ghosh S, Palmer S, Rodrigues N et al. (1993) Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nature Genet 4: 404-409
50. Corbett JA, Mikhael A, Shimizu J et al. (1993) Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci USA 90: 8992-8995
51. Kleemann R, Rothe H, Kolb-Bachofen V et al. (1993) Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett 328: 9-12
52. Reimers JI, Andersen HU, Mauricio D et al. (1996) Strain-dependent differences in sensitivity of rat betacells to IL-1β in vitro and in vivo. Diabetes "in press"
53. Xu W, Charles IG, Moncada S, Gorman P, Sheer D, Liu L. Emson P (1994) Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively. Genomics 21: 419-422
54. Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC (1994) Differential expression and induction of mRNAs encoding two inducible nitric oxide synthase in rat kidney. Kidney Int 46: 653-665
55. Bloch KD, Wolfram JR, Brown DM et al. (1995) Three members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2c) colocalize to human chromosome 17. Genomics 27: 526-530
56. Xu W, Charles IG, Liu L. Koni PA, Moncada S, Emson P (1995) Molecular genetic analysis of the duplication of human inducible nitric oxide synthase (NOS2) sequences. Biochem Biophys Res Commun 212: 466-472
57. Xie Q-W, Whisnant R, Nathan C (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177: 1779-1784
58. Lowenstein CJ, Alley EW, Raval P et al. (1993) Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730-9734
59. Nunokawa Y, Ishida N, Tanaka S (1994) Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Commun 200: 802-807
60. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182: 1683-1693
61. Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2412
62. Spink J, Cohen J, Evans TJ (1995) The cytokine responsive smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor (greek small letter script kappa)B. J Biol Chem 270: 29541-29547
63. Chu SC, Wu H-P, Banks TC, Eissa NT, Moss J (1995) Structural diversity on the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem 270: 10625-10630
64. De Vera ME, Shapiro RA, Nussler AK et al. (1996) Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93: 1054-1059
65. Sachs AB (1993) Messenger RNA degradation in eukaryotes. Cell 74: 413-421
66. Evans T, Carpenter A, Cohen J (1994) Inducible nitric oxide synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process. Eur J Biochem 219: 563-569
67. 2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability. J Cell Biol 129: 1651-1657
68. Vodovotz Y, Bogdan C, Paik J, Xie Q-W, Nathan C (1993) Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 178: 605-613
69. Niemann A, Björklund A, Eizirik DL (1994) Studies on the molecular regulation of the inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Mol Cell Endocrinol 106: 151-155
70. Eizirik DL, Björklund A, Welsh N (1993) Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett 317: 62-66
71. Park SK, Lin HL, Murphy S (1994) Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells. Biochem Biophys Res Commun 201: 762-768
72. Colasanti M, Persichini T, Menegazzi M et al. (1995) Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem 270: 26731-26733
73. Nussler AK, Billiar TR, Liu Z-Z, Morris SM Jr (1994) Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. J Biol Chem 269: 1257-1261
74. Peng H-B, Libby P, Liao JK (1995) Induction and stabilization of I(greek small letter script kappa)B alpha by nitric oxide mediates inhibition of NF-(greek small letter script kappa)B. J Biol Chem 270: 14214-14219
75. Griscavage JM, Rogers NE, Sherman MP, Ignarro LJ (1993) Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J Immunol 151: 6329-6337
76. Mandrup-Poulsen T, Corbett JA, McDaniel ML, Nerup J (1993) What are the types and cellular sources of free radicals in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 470-473
77. Cetkovic-Cvrlje M, Sandier S, Eizirik DL (1993) Nicotinamide and dexamethasone inhibit interleukin-1-induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase. Endocrinology 133: 1739-1743
78. Corbett JA, Kwon G, Misko TP, Rodi CP, McDaniel ML (1994) Tyrosine kinase involvement in IL-1β-induced expression of iNOS by β-cells purified from islets of Langerhans. Am J Physiol 267: C48-C54
79. Corbett JA, McDaniel ML (1995) Intraislet release of interleukin-1 inhibits β-cell function by inducing β-cell expression of inducible nitric oxide synthase. J Exp Med 181: 559-568
80. Cetkovic-Cvrlje M, Eizirik DL (1994) TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6: 399-406
81. Flodström M, Niemann A, Bedoya FJ, Morris SM Jr, Eizirik DL (1995) Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic β-cells: induction of argininosuccinate synthase by cytokines. Endocrinology 136: 3200-3206
82. Bigdeli N, Niemann A, Sandier S, Eizirik DL (1994) Dissociation between interleukin-1β-induced expression of mRNA for Superoxide dismutase and nitric oxide synthase in insulin-producing cells. Biochem Biophys Res Commun 203: 1542-1547
83. Messmer U, Brüne B (1994) Modulation of inducible nitric oxide synthase in RINm5F cells. Cell Signal 6: 17-24
84. Andersen HU, Mauricio D, Karlsen AE, Mandrup-Poulsen T, Nielsen JH, Nerup J (1996) Interleukin-1β-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine. Eur J Endocrinol 134: 251-260
85. Liew FY, Li Y, Severn A, Millot S, Schmidt J, Salter M, Moncada S (1992) A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 21: 2489-2494
86. Cunha FO, Moncada S, Liew FY (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by Interferon γ in murine macrophages. Biochem Biophys Res Commun 182: 1155-1159
87. Sandler S, Welsh N (1993) Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1. Biochem Biophys Res Commun 195: 859-865
88. Pinsky DJ, Cai B, Yang X, Rodriquez. C, Sciacca RR, Cannon PJ (1995) The lethal effects of cytokine-induced nitric oxide on cardiac myocites are blocked by nitric oxide synthase antagonism or transforming growth factor β. J Clin Invest 95: 677-685
89. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Nagineni CN (1995) Transforming growth factor-β inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem Biophys Res Commun 215: 386-393
90. Marbley JG, Cunningham JM, Schulster D, Green IC (1994) Transforming growth factor β 1 protects rat islets from the inhibitory effects of interleukin-1 on insulin secretion. Diabetologia 37 [Suppl 1 ]: A44 (Abstract)
91. Hao W, Palmer JP (1995) Recombinant human transforming growth factor β does not inhibit the effects of interleukin-1β on pancreatic islet cells. J Interferon Cyt Res 15: 1075-1082
92. Dayer-Métroz MD, Wollheim CB, Seckinger P, Dayer JM (1989) A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmun 2: 163-171
93. Hammonds P, Beggs M, Beresford G, Espinal J, Clarke J, Mertz. RJ (1990) Insulin-secreting β-cells possess specific receptors for interleukin-1β .FEBS Lett 261: 97-100
94. Eizirik DL, Tracey DE, Bendtzen K, Sandler S (1991) An interleukin-1 receptor antagonist protein protects insulinproducing beta cells against suppressive effects of interleukin-1β. Diabetologia 34: 445-448
95. Eizirik DL, Tracey DE, Bendtzen K, Sandler S (1992) Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic β-cells. Autoimmunity 12: 127-133
96. Zumsteg U, Reimers JI, Pociot F et al. (1993) Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats. Diabetologia 36: 759-766
97. Bristulf J, Gatti S, Malinowksy D, Björk L, Sundgren AK, Barfai T (1994) Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line RINm5F; sequencing a rat type II interleukin-1 receptor cDNA. Eur Cytokine Net 5: 319-330
98. Jafarian-Tehrani M, Amrani A, Homo-Delarche F, Marquette C, Dardenne M, Haour F (1995) Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonobese diabetic mice. Endocrinology 136: 609-613
99. Taniguchi T (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268: 251-255
100. Martin M, Bol GF, Eriksson A, Resch K, Brigelius-Flohe R (1994) Interleukin-1-induced activation of a protein kinase coprecipitating with the type 1 interleukin-1 receptor in T cells. Eur J Immunol 24: 1566-1571
101. Croston GE, Cao Z, Goeddel DV (1995) NF-(greek small letter script kappa)B activation by interleukin-1 (IL-1) requires an IL-1-receptor-associated protein kinase activity. J Biol Chem 270: 16514-16517
102. Cao Z, Henzel WJ, Gao X (1996) IRAK: a kinase associated with the interleukin-1 receptor. Science 271: 1128-1131
103. Grimm S, Baeuerle PA (1993) The inducible transcription factor NF-(greek small letter script kappa) B: structure-function relationship of its protein subunits. Biochem J 290: 297-308
104. Lenardo MJ, Pierce JW, Baltimore D (1987) Protein-hinding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236: 1573-1577
105. Saldeen J, Welsh N (1994) Interleukin-1β induced activation of NF-(greek small letter script kappa) B in insulin producing RINm5F cells is prevented by the protease inhibitor Nα-p-tosyl-l-lysine choromethylketone. Biochem Biophys Res Commun 203: 149-155
106. Welsh N, Bendtzen K, Sandler S (1991) Influence of protease on inhibitory and stimulatory effects of interleukin1β on β-cell function. Diabetes 40: 290-294
107. Henkel T, Macleidt T, Alkalay I, Krönke M, Ben-Neriah Y, Baeuerle PA (1993) Rapid proteolysis of I(greek small letter script kappa) B-α is necessary for activation of transcription factor NF-(greek small letter script kappa)B. Nature 365: 182-185
108. Bedoya FJ, Flodström M, Eizirik DL (1995) Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not Superoxide dismutase mRNA, in insulin producing cells. Biochem Biophys Res Commun 210: 816-822
109. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML (1995) Interleukin-1β-induced nitric oxide synthase expression by rat pancreatic β-cells: Evidence for the involvement of nuclear factor (greek small letter script kappa)B in the signaling mechanism. Endocrinology 136: 4790-4795
110. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor (greek small letter script kappa)B activation in intact cells. J Exp Med 175: 1181-1194
111. Welsh N, Margulis B, Bendtzen K, Sandler S (1994) Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide- but not interleukin-1β-induced inhibition of glucose metabolism in rat pancreatic islets. J Endocrinol 143: 152-156
112. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910-1917
113. Flodström M, Welsh N, Eizirik DL (1996) Cytokines activate the nuclear factor (greek small letter script kappa)B (NF-(greek small letter script kappa)B) and induce nitric oxide production in human pancreatic islets. FEBS Lett: 385: 4-6
114. Kamijo R, Harada H, Matsuyama T et al. (1994) Requirement for transcription factor 1RF-1 in NO synthase induction in macrophages. Science 263: 1612-1615
115. Akabane A, Kato I, Takasawa S et al. (1995) Nicotinamide inhibits IRF-I mRNA induction and prevents IL-1β-induced nitric oxide synthase expression in pancreatic β cells. Biochem Biophys Res Commun 215: 524-530
116. Hughes JH, Watson MA, Easom RA, Turk J, McDaniel ML (1990) Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified β-cells. FEBS Lett 266: 33-36
117. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072: 129-157
118. Dérijard B, Hibi M, Wu I-H et al. (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylated the c-Jun activation domain. Cell 76: 1025-1037
119. Coso OA, Chiariello M, Yu J-C et al. (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signalling pathway. Cell 81: 1137-1146
120. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185
121. Rouse J, Cohen P, Trigon S et al. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027-1037
122. Sanchez I, Hughes RT, Mayer BJ et al. (1994) Role of SAPK/ERK kinase-1 in the stress-activated pathway reg ulating transcription factor c-Jun. Nature 372: 794-798
123. Gupta S, Campbell D, Dérijard B, Davis RJ (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393
124. Verheij M, Bose R, Lin XH et al. (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75-79
125. Westwick JK, Bielawska AE, Dbaibo G, Hannun YA, Brenner DA (1995) Ceramide activates the stress-activated protein kinases. J Biol Chem 270: 22689-22692
126. Wolff RA, Dobrowsky RT, Bielawska A, Abeid LM, Hannun YA (1994) Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 269: 19605-19609
127. 2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 271: 8307-8312
128. Eizirik DL, Sandler S, Welsh N, Juntti-Berggren L, Berggren P-O (1995) Interleukin-1β-induced stimulation of insulin release in mouse pancreatic islets is related to diacylglycerol production and protein kinase C activation. Mol Cell Endocrinol 111: 159-165
129. Arkhammar P, Nilsson T, Welsh M, Welsh N, Berggren PO (1989) Effects of protein kinase C activation on the regulation of the stimulus-secretion coupling in pancreatic β-cells. Biochem J 264: 207-215
130. Schutze S, Potthoff K, Macleidt T et al. (1992) TNF activates NF-(greek small letter script kappa) B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71: 765-776
131. Kolesnick RN (1987) 1,2-diacylglycerols, but not phorbol esters, stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J Biol Chem 262: 16759-16762
132. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, Chojkier M (1993) Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364: 544-547
133. Poli V, Mancini FP, Cortese R (1990) IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins to C/EBP. Cell 63: 643-653
134. Prestera T, Talalay P, Alam J, Ahn YI, Lee PJ, Choi MK (1995) Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1: 827-837
135. Welsh N (1994) A role for tyrosine kinase activation in interleukin-1β induced nitric oxide production in the insulin producing cell line RINm5F. Bioscience Rep 14: 43-50
136. Tetsuka T, Srivastava SK, Morrison AR (1996) Tyrosine kinase inhibitors, genistein and herbimycin A do not block interleukin-1β-induced activation of NF-(greek small letter script kappa)B in rat mesangial cells. Biochem Biophys Res Commun 218: 808-812
137. Andersen HU, Larsen PM, Fey SJ, Karlsen AE, Mandrup-Poulsen T, Nerup J (1995) Two dimensional gel electrophoresis of rat islet proteins. Interleukin-1β-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes 44: 400-407
138. Morris SM Jr, Billiar TR (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266: E829-E839
139. Iyengar R, Stuher D, Marietta M (1987) Macrophage synthesis of nitrite, nitrate, and N-nitrosoamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA 84: 6369-6373
140. Albina JE, Mills CD, Barbul A et al. (1988) Arginine metabolism in wounds. Am J Physiol 254: E459-467
141. Hattori Y, Cambell EB, Gross SS (1994) Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration of arginine for nitric oxide synthesis. J Biol Chem 269: 9405-9408
142. Nagasaki A, Gotoh T, Takeya M et al, (1996) Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rat. J Biol Chem 271: 2658-2662
143. Wang WW, Jenkinson CP, Griscavage JM et al. (1995) Coinduction of arginase and nitric oxidase synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 210: 1009-1016
144. Sener A, Blaicher F, Malaisse WJ (1988) Production of urea but absence of urea cycle in pancreatic islet cells. Med Sci Res 16: 483-484
145. (1)-hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem Biophys Res Commun 203: 1614-1621
146. Corbett JA, Kwon G, Turk J, McDaniel ML (1993) IL-1β induces coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32: 13767-13770
147. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244
148. Bleich D, Chen S, Gu J-L et al. (1995) Interleukin-1β regulates the expression of a leukocyte type of 12-lypoxygenase in rat islets and RINm5F cells. Endocrinology 136: 5736-5744
149. Ma Z, Ramanadham S, Corbett JA et al. (1996) Interleukin-1 enhances pancreatic islet arachidonic acid 12-lypoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanism. J Biol Chem 271: 1029-1042
150. Eizirik DL, Strandell E, Bendtzen K, Sandler S (1988) Functional characteristics of rat pancreatic islets maintained in tissue culture following exposure to interleukin-1. Diabetes 37: 916-919
151. Borg LAH, Cagliero E, Sandler S, Welsh N, Eizirik DL (1992) Interleukin-1β increases the activity of Superoxide dismutase in rat pancreatic islets. Endocrinology 130: 2851-2857
152. Eizirik DL, Welsh M, Strandell E, Welsh N, Sandler S (1990) Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127: 2290-2297
153. Welsh N, Welsh M, Lindquist S, Eizirik DL, Bendtzen K, Sandler S (1991) Interleukin-1β increases the biosynthesis of the heal shock protein hsp70 and specifically decreases the biosynthesis of five proteins in rat pancreatic islets. Autoimmunity 9: 33-40
154. Helqvist S, Polla BS, Johannensen JH, Nerup J (1991) Heat shock protein induction in rat pancreatic islets by human recombinant interleukin-1β. Diabetologia 34: 150-156
155. Welsh N, Margulis B, Borg LAH et al. (1995) Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol Med 1: 806-820
156. Strandell E, Buschard K, Saldeen J, Welsh N (1995) Interleukin-1β induces the expression of hsp70. heme oxygenase and MnSOD in FACS purified rat islet β-cells, but not in α-cells. Immunol Lett 48: 145-148
157. Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79: 319-326
158. Darley-Usmar VM, Hogg N, O'Leary WJ, Wilson MT, Moncada S (1992) The simultaneous generation of Superoxide anion and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Rad Res Commun 17: 9-20
159. Hausladen A, Fridovich I (1994) Superoxide and peroxynitrite inactivate aconitase, nitric oxide does not. J Biol Chem 269: 29405-29408
160. Castro L, Rodriguez M, Radi R (1994) Aconitase is readily inactivated by peroxynitrite, hut not by its precursor, nitric oxide. J Biol Chem 269: 29409-29415
161. Margulis BA, Sandier S, Eizirik DL, Welsh N, Welsh M (1991) Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1β-induced impaired β-cell function. Diabetes 40: 1418-1422
162. Bellman K, Wenz A, Radons J, Burkart V, Kleeman R, Kolb H (1995) Heat shock induces resistance in rat pancreatic islets against nitric oxide, oxygen radicals and streptozotocin toxicity. J Clin Invest 95: 2840-2845
163. Wei X, Charles IG, Smith A et al. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411
164. MacMicking JD, Nathan C, Hom G et al. (1995) Altered response to bacterial infection and endoloxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650
165. Leubach VE, Shesely EG, Smithies O, Sherman PA (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92: 10688-10692
166. James J (1993) The music of the spheres. Litlle, Brown and Company, London